openPR Logo
Press release

Recombinant Therapeutic Antibodies and Proteins Market To Exhibit Steadfast Growth 2018-2026 by Global Top Players - Merck & Co., Novo Nordisk, Pfizer Inc., Sanofi S.A., Abbott, Amgen Inc., Biogen Inc., Eli Lilly and Company, Johnson and Johnson

11-09-2018 03:37 PM CET | Health & Medicine

Press release from: Coherent Market Insights - Biotechnology

Global Recombinant Therapeutic Antibodies and Proteins Market

Global Recombinant Therapeutic Antibodies and Proteins Market

Therapeutic proteins are engineered in the laboratory for pharmaceutical use, including non-covalent binders. These proteins are highly effective and serve as the modernized treatment for rare as well as chronic diseases. Protein therapeutics offer custom-made treatment approach by supporting a specifically targeted therapeutic process by compensating the deficiency of an essential protein. Recombinant proteins have gained significant traction for therapeutic applications and the number of proteins either launched or approved into clinical trials has continually increased over the past two decades. According to the National Center for Biotechnology Information (NCBI) data of 2017, the U.S. Food and Drug Administration (FDA) approved over 140 recombinant therapeutic proteins for human use and several hundred are currently in development. Majority of these proteins are recombinant monoclonal antibodies.

The global recombinant therapeutic antibodies and proteins market size was valued at US$ 91.2 billion in 2017 and is expected to witness a robust CAGR of 12.2% over the forecast period (2018 – 2026).

Download PDF Brochure of Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1981

Market Dynamics:

Recombinant therapeutic proteins and antibodies have gained high traction in clinical applications. Due to the development of antibody-based therapeutics, mammalian expression systems have experienced a major boost and microbial expression systems continue to be widely used in industries, which in turn will fuel the growth of the market. However, variations in production methods of therapeutic antibodies can lead to differences in their structure, based on the selection of recombinant procedure. Most protein therapeutics available in the market are recombinant and the majority of them are in clinical trials for therapy of immune disorders, cancers, infections, and other diseases. Various engineered proteins, including multi-specific fusion proteins, bi-specific monoclonal antibodies (mAbs) and mAbs conjugated small molecule drugs, and proteins with optimized pharmacokinetics are under development.

Advancements in recombinant therapeutic drugs are expected to bolster the recombinant therapeutic antibodies and proteins market growth

Integration of novel approaches and strategies to modify protein drug products is an important aspect. Advancements in recombinant protein technologies have allowed drug manufacturers and developers to adjust the required functional characteristics of proteins of interest while maintaining product efficacy and safety.

Various recombinant technologies are currently in use to increase the half-life, functionality, and targeting of novel therapeutic protein drugs and increase product purity and volume. For instance, protein conjugation and derivatization methods, including albumin-fusion15, PEGylation, and Fc-fusion are currently being used to extend a drug’s circulating half-life.

Major Players Operating In The Global Recombinant Therapeutic Antibodies And Proteins Market:

Abbott, Amgen Inc., Biogen Inc., Eli Lilly and Company, F. Hoffmann-La Roche, Johnson and Johnson, Merck & Co., Novo Nordisk, Pfizer Inc., and Sanofi S.A.

Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/1981

Detailed Segmentation:

Global Recombinant Therapeutic Antibodies and Proteins Market, By Drug Class:
Plasma Protein
Growth Factors
Fusion Proteins
Monoclonal Antibodies
Hormones
Enzyme
Coagulation Factors
Others

Global Recombinant Therapeutic Antibodies and Proteins Market, By Application:
Oncology
Hematology
Immunology
Endocrinology
Infectious Disease
Cardiovascular Diseases
Others

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Recombinant Therapeutic Antibodies and Proteins Market To Exhibit Steadfast Growth 2018-2026 by Global Top Players - Merck & Co., Novo Nordisk, Pfizer Inc., Sanofi S.A., Abbott, Amgen Inc., Biogen Inc., Eli Lilly and Company, Johnson and Johnson here

News-ID: 1359300 • Views:

More Releases from Coherent Market Insights - Biotechnology

Wearable Patch Market 2030 Emerging Trends and Global Demand During the COVID-19 Period till 2027 | Medtronic Plc, Hill-Rom Holdings, iRhythm Technologies
Wearable Patch Market 2030 Emerging Trends and Global Demand During the COVID-19 …
Coherent Market Insights published a report, titled,"Wearable Patch Market, by Technology (Connected and Regular), by Application (Monitoring, Drug Delivery, and Diagnostics), by End User (Healthcare and Fitness & Sports), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027." Wearable patches are used for monitoring and diagnosis of chronic diseases. Increasing prevalence of diseases such as atrial
Recombinant Protein Market To Witness Robust Expansion Throughout The Forecast Period 2017 - 2025 And The Top Competitors Are Crown Bioscience, ProSpec Tany TechnoGene, BPS Bioscience, Sigma Aldrich Company, Novoprotein Scientific
Recombinant Protein Market To Witness Robust Expansion Throughout The Forecast P …
Recombinant proteins have immense potential in cancer therapy research and development. For instance, growth factors, immune checkpoint, and cell damage & oxidative stress proteins (preclinical stage) are utilized from recombinant proteins category for cancer therapy research. Increased understanding of oncogenic signaling pathways and proteins involved in the same has increased the targeting ways, wherein, recombinant proteins such as immune checkpoint, growth factors, and antibodies are used. These proteins are used
Biosimilar Pipeline Analysis Market Outlook 2019: Rapidly Develop by key Players Biocon, Pfizer Inc., F. Hoffmann-La Roche Ltd, Amgen Inc., Kyowa Pharmaceutical Industry Co. Ltd, Boehringer Ingelheim GmbH, AstraZeneca, Novartis AG, and Merck & Co
Biosimilar Pipeline Analysis Market Outlook 2019: Rapidly Develop by key Players …
Biosimilar market is under the initial phase of development, they are used for the treatment of various disorders such as autoimmune disease, cancer as per National Institute of Health 2012 report, there were more than 23.5 million people living with autoimmune disease in the U.S. and low pricing of biosimilar drugs make them affordable for people. The same mechanism of action provides effective treatment for disease along with increased awareness
Cancer Biomarkers Market Rapid Growth 2019 by leading players BioMerieux S.A., Bard1 Life Sciences Limited, Bio-Rad Laboratories, Abbott Laboratories, Becton, Dickinson and Company, Merck & Co., Inc., Qiagen N.V., and Thermo Fisher Scientific Inc
Cancer Biomarkers Market Rapid Growth 2019 by leading players BioMerieux S.A., B …
The global cancer biomarkers market is projected to witness significant growth over the forecast period, owing to rising incidence and prevalence of various cancer types, including breast cancer, lung cancer, kidney cancer, liver cancer, prostate cancer, and among others. Moreover, other factors impacting growth of cancer biomarkers market includes rising research and development activities in developing cancer biomarker and rising demand for personalized medicine in cancer therapies. Free Request Sample Copy

All 5 Releases


More Releases for Protein

Astonishing growth in Dairy Protein Market Growth? Milk Protein Isolates (MPIs), …
Dairy Protein Market Business Insights and Updates: The latest Market report by a Data Bridge Market Research with the title [Global Dairy Protein Market - Industry Trends and Forecast to 2026] . Dairy Protein Market research analysis and data lend a hand to businesses for the planning of strategies related to COVID-19 impact on industry, investment, revenue generation, production, product launches, costing, inventory, purchasing and marketing. Dairy Protein market insights with
Global Plant Protein Market 2019 – Soy Protein, Wheat Protein, Pea Protein | K …
The Global Pea Protein Market Research Report conducts a deep estimation on the present state of Pea Protein Industry with the definition, classification and market scope. The fundamental Pea Protein Industry aspects like competitive landscape structure, eminent industry players, Pea Protein Market size and value is studied. The Pea Protein Market growth trends, development plans, dynamic market driving factors and risk assessment is conducted. All the traders, dealers, distributors of
Protein Packaging Market Report 2018: Segmentation by Product (Rigid packaging, …
Global Protein Packaging market research report provides company profile for Amcor Limited, DuPont, Flexifoil Packaging Pvt., Swiss Pac Private Ltd. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides detailed
Whey Protein Ingredients Market by Type (Whey Protein Concentrate 80 and Whey Pr …
Whey Protein Ingredients Market Report, published by Allied Market Research, projects that the global market was valued at $8,216 million in 2015, and is projected to reach $15,037 million by 2022, growing at a CAGR of 9.2% from 2016 to 2022. The whey protein concentrate segment held more than two-fifths of the total market share in 2015. Access Full Summary at: https://www.alliedmarketresearch.com/whey-protein-ingredients-market Whey proteins are derived from whey during the cheese production
Neutral Alternative Protein Market Report 2018: Segmentation by Type (Plant Prot …
Global Neutral Alternative Protein market research report provides company profile for Tereos Syral, CP Kelco, Davisco, Meelunie, Danisco (DuPont), Kerry Group, Cargill, Archer Daniels Midland Company, Glanbia, CHS and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018
Protein Bars Market, By Protein Source Type, Product Type, Protein Content
Protein Bars Market Outlook: North America held a dominant position in the global protein bars market in 2016, with S. being the major contributor. Increasing awareness regarding protein supplements and growing demand for convenience food in the region are key drivers for growth of the market in North America. Additionally, according to the U.S. Department of Labor, average daily participation rates in sports and exercise rose by 3.6% from 2003 to